Globus Medical Financials - Benzinga

Globus Medical Inc

GMEDNYSE

Trade with Public

Trade with Public

$81.37

-1.60-1.93%

At close: Aug 31, 5:00 PM EST

$81.37

N/A

After Hours: 4:02 PM EST

M&A: Higgs Boson Health was acquired by Globus Medical (GMED) on Wednesday, August 26, 2026

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Globus Medical Financials

Globus Medical (GMED) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Globus Medical Raises FY2026 Adj EPS Guidance from $4.70-$4.80 to $4.95-$5.05 vs $4.74 Est; Affirms FY2026 Sales Guidance of $3.180B-$3.220B vs $3.201B Est

Globus Medical (NYSE:GMED) raises FY2026 Adj EPS guidance from $4.70-$4.80 to $4.95-$5.05 vs $4.74 analyst estimate. Affirms FY2026 sales outlook from $3.180 billion-$3.220 billion to $3.180 billion-$3.220 billion vs

Benzinga Newsdesk

PRO
Globus Medical Q2 Adj. EPS $1.34 Beats $1.10 Estimate, Sales $789.612M Beat $782.840M Estimate

Globus Medical (NYSE:GMED) reported quarterly earnings of $1.34 per share which beat the analyst consensus estimate of $1.10 by 21.82 percent. This is a 55.81 percent increase over earnings of $0.86 per share from the

Benzinga Newsdesk

PRO
Globus Medical Raises FY2026 Adj EPS Guidance from $4.40-$4.50 to $4.70-$4.80 vs $4.47 Est; Affirms FY2026 Sales Guidance of $3.180B-$3.220B vs $3.202B Est

Globus Medical (NYSE:GMED) raises FY2026 Adj EPS guidance from $4.40-$4.50 to $4.70-$4.80 vs $4.47 analyst estimate. Affirms FY2026 sales outlook from $3.180 billion-$3.220 billion to $3.180 billion-$3.220 billion vs

Benzinga Newsdesk

PRO
Globus Medical Q1 Adj. EPS $1.12 Beats $0.92 Estimate, Sales $759.854M Beat $736.999M Estimate

Globus Medical (NYSE:GMED) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $0.92 by 21.74 percent. This is a 64.71 percent increase over earnings of $0.68 per share from the

Benzinga Newsdesk

PRO
Globus Medical Raises FY2026 Adj EPS Guidance from $4.30-$4.40 to $4.40-$4.50 vs $4.26 Est; Affirms FY2026 Sales Guidance of $3.180B-$3.220B vs $3.165B Est

Benzinga Newsdesk

PRO
Globus Medical Q4 Adj. EPS $1.28 Beats $1.15 Estimate, Sales $826.420M Beat $799.123M Estimate

Benzinga Newsdesk